These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2338269)

  • 1. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
    Dubé R; Rook GA; Steele J; Brealey R; Dwek R; Rademacher T; Lennard-Jones J
    Gut; 1990 Apr; 31(4):431-4. PubMed ID: 2338269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.
    Safaie P; Ham M; Kuang P; Mehta AS; Wang M; Cheifetz AS; Robson S; Lau D; Block TM; Moss AC
    Inflamm Bowel Dis; 2013 Dec; 19(13):2796-800. PubMed ID: 24185312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
    Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.
    Nakajima S; Iijima H; Shinzaki S; Egawa S; Inoue T; Mukai A; Hayashi Y; Kondo J; Akasaka T; Nishida T; Kanto T; Morii E; Mizushima T; Miyoshi E; Tsujii M; Hayashi N
    Inflamm Bowel Dis; 2011 Apr; 17(4):927-36. PubMed ID: 20824817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.
    Filley E; Andreoli A; Steele J; Waters M; Wagner D; Nelson D; Tung K; Rademacher T; Dwek R; Rook GA
    Clin Exp Immunol; 1989 Jun; 76(3):343-7. PubMed ID: 2787714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
    Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease.
    MacDermott RP; Nash GS; Auer IO; Shlien R; Lewis BS; Madassery J; Nahm MH
    Gastroenterology; 1989 Mar; 96(3):764-8. PubMed ID: 2914639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
    Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
    Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
    Giaffer MH; Clark A; Holdsworth CD
    Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
    Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
    Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
    Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
    Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
    Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.
    Sawyerr AM; Pottinger BE; Savage CO; Bradley NJ; Hudson M; Wakefield AJ; Pearson JD; Pounder RE
    Dig Dis Sci; 1994 Sep; 39(9):1909-17. PubMed ID: 8082497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells.
    Auer IO; Grosch L; Hardörfer C; Röder A
    Gut; 1988 Dec; 29(12):1639-47. PubMed ID: 3220303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing acute phase responses in Crohn's disease and ulcerative colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
    Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
    Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
    Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.